cGAS/STING signaling pathway in gynecological malignancies: From molecular mechanisms to therapeutic values
Authors:
Open Access
- 30 January 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1525736
Abstract
Gynecological cancers, including cervical, ovarian, and endometrial malignancies, remain a significant global health burden, exacerbated by disparities in access to preventive measures such as HPV vaccination and routine screening. The cGAS/STING signaling pathway, a pivotal mechanism in innate immunity, detects cytosolic DNA from pathogens or cellular damage, triggering immune responses via type I interferons and inflammatory cytokines. This pathway’s dual role in gynecological cancers, either promoting antitumor immunity or facilitating tumor immune evasion, makes it a compelling target for innovative therapies. The article outlines cGAS/STING’s influence on tumor microenvironments, immune surveillance, and inflammation, with emphasis on molecular mechanisms driving cancer progression. It explores interactions between DNA damage response pathways and immune modulation, highlighting the impact of cGAS/STING activation or suppression in ovarian, cervical, and endometrial cancers. The therapeutic potential of STING agonists, PARP inhibitors, and targeted immunotherapies is reviewed, demonstrating how these approaches can boost immune responses, counteract chemotherapy resistance, and improve patient outcomes. The study also discusses strategies for leveraging cGAS/STING signaling to enhance the efficacy of immunotherapies and address tumor-mediated immune suppression, providing insights into future directions for personalized cancer treatments.Keywords
This publication has 122 references indexed in Scilit:
- CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian CancerAdvanced Science, 2024
- Precision matters: the value of PET/CT and PET/MRI in the clinical management of cervical cancerStrahlentherapie und Onkologie, 2024
- Clinical characteristics, treatment, and outcomes of nivolumab induced immune thrombocytopeniaInvestigational New Drugs, 2024
- Lamin B1 curtails early human papillomavirus infection by safeguarding nuclear compartmentalization and autophagic capacityCellular and Molecular Life Sciences, 2024
- cGAS‐STING signaling in cancer: Regulation and therapeutic targetingMedComm – Oncology, 2023
- New insights for gynecological cancer therapies: from molecular mechanisms and clinical evidence to future directionsCancer and Metastasis Reviews, 2023
- CircELK4 Contributes to Lupus Nephritis by Acting as a miR-27b-3p Sponge to Regulate STING/IRF3/IFN-I SignalingInflammation, 2021
- Activation of STING inhibits cervical cancer tumor growth through enhancing the anti-tumor immune responseMolecular and Cellular Biochemistry, 2020
- INH14, a Small‐Molecule Urea Derivative, Inhibits the IKKα/β‐Dependent TLR Inflammatory ResponseChemBioChem, 2018
- IKKβ/NF-κB mediated the low doses of bisphenol A induced migration of cervical cancer cellsArchives of Biochemistry and Biophysics, 2015